Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioning.

作者信息

Bilmon I, Nivison-Smith I, Hertzberg M, Ritchie D, Greenwood M, Spencer A, Kennedy G, Bryant A, Moore J

机构信息

1] Department of Haematology, St Vincent's Hospital, Darlinghurst, New South Wales, Australia [2] Department of Haematology, Westmead Hospital, Westmead, New South Wales, Australia.

Australasian Bone Marrow Transplant Recipient Registry, Darlinghurst, New South Wales, Australia.

出版信息

Bone Marrow Transplant. 2014 Jun;49(6):852-3. doi: 10.1038/bmt.2014.23. Epub 2014 Mar 3.

DOI:10.1038/bmt.2014.23

PMID:24583626

Abstract

摘要

相似文献

[1]

Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioning.

Bone Marrow Transplant. 2014-6

[2]

Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas.

Bone Marrow Transplant. 2011-2-28

[3]

Allogeneic hematopoietic cell transplantation using fludarabine plus myeloablative busulfan and melphalan confers promising survival in high-risk hematopoietic neoplasms: a single-center retrospective analysis.

Hematology. 2021-12

[4]

Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma.

Br J Haematol. 2020-8

[5]

Allogeneic stem cell transplantation for patients with advanced hematological malignancies: comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning.

J Korean Med Sci. 2007-4

[6]

Reduced intensity conditioning with thiotepa, fludarabine, and melphalan is effective in advanced multiple myeloma.

Leuk Lymphoma. 2007-4

[7]

Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation.

Bone Marrow Transplant. 2006-10

[8]

Successful autologous hematopoietic stem cell transplantations for severe multiple sclerosis with fludarabine and cyclophosphamide conditioning.

Int J Hematol. 2006-5

[9]

Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.

Hematol Oncol. 2017-3

[10]

Reduced-intensity conditioning followed by peripheral blood stem cell transplantation for adult patients with high-risk acute lymphoblastic leukemia.

Biol Blood Marrow Transplant. 2009-11

本文引用的文献

[1]

Fludarabine Melphalan reduced-intensity conditioning allotransplanation provides similar disease control in lymphoid and myeloid malignancies: analysis of 344 patients.

Bone Marrow Transplant. 2014-1

[2]

Second allograft for hematologic relapse of acute leukemia after first allogeneic stem-cell transplantation from related and unrelated donors: the role of donor change.

J Clin Oncol. 2013-8-5

[3]

Nonmyeloablative second transplants are associated with lower nonrelapse mortality and superior survival than myeloablative second transplants.

Biol Blood Marrow Transplant. 2010-6-14

[4]

ASH evidence-based guidelines: is there a role for second allogeneic transplant after relapse?

Hematology Am Soc Hematol Educ Program. 2009

[5]

A retrospective review of the outcome after second or subsequent allogeneic transplantation.

Biol Blood Marrow Transplant. 2009-4

[6]

Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant.

Bone Marrow Transplant. 2008-12

[7]

Reduced-intensity conditioning regimens for hematologic malignancies: what have we learned over the last 10 years?

Hematology Am Soc Hematol Educ Program. 2005

[8]

Nonmyeloablative allogeneic stem cell transplantation (NST) after truly nonmyeloablative and reduced intensity conditioning regimens.

Crit Rev Oncol Hematol. 2004-9

[9]

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.

Bone Marrow Transplant. 2004-10

[10]

Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation.

J Clin Oncol. 2001-8-15

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Outcomes following second allogeneic haematopoietic transplants using fludarabine-melphalan conditioning.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

本文引用的文献